From Renal Biomarkers to Therapeutic Targets: The Use of Monocyte Chemoattractant Protein 1, Transforming Growth Factor-Beta, and Connective Tissue Growth Factor in Diabetic Nephropathy and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
In an ideal world, every condition would have a sensitive and specific marker that could be measured in a noninvasive or minimally invasive way. Instead, the medical community depends on invasive biomarkers, which carry inherent risks, to make a diagnosis and plan treatment. In this review article,...
Main Authors: | Katrina J Spensley, Frederick W. K. Tam |
---|---|
Format: | Article |
Language: | English |
Published: |
European Medical Journal
2018-12-01
|
Series: | European Medical Journal |
Subjects: | |
Online Access: | https://www.emjreviews.com/nephrology/article/from-renal-biomarkers-to-therapeutic-targets-the-use-of-monocyte-chemoattractant-protein-1-transforming-growth-factor-beta-and-connective-tissue-growth-factor-in-diabetic-nephropathy-and-antineutro/ |
Similar Items
-
Rheumatoid factor is correlated with disease activity and inflammatory markers in antineutrophil cytoplasmic antibody-associated vasculitis
by: Shinji Watanabe, et al.
Published: (2017-12-01) -
Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
by: Zhi-Ying Li, et al.
Published: (2020-08-01) -
Minocycline-induced antineutrophil cytoplasmic antibody-associated vasculitis in children
by: Sunil Kapur, et al.
Published: (2021-01-01) -
ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS IN “REAL LIFE” – SERIES OF CLINICAL CASES IN A ROMANIAN REFERENCE CENTER
by: Mihaela-Lavinia Popescu, et al.
Published: (2017-12-01) -
Acute respiratory failure as primary manifestation of antineutrophil cytoplasmic antibodies-associated vasculitis
by: Evdokia Sourla, et al.
Published: (2014-07-01)